Treg modulation has been hypothesized as one of the mechanisms by which antitumor necrosis factor α (TNFα) agents exert their action in rheumatoid arthritis (RA) andinflammatory bowel disease (IBD). This evidence concerns the gene TNF and inflammatory bowel disease.